Background: Vulvovaginal candidiasis (VVC) is the second most common vaginal infection. HIV-infection is a risk factor for this infection. Objective: To determine the frequency of VVC and to describe the main Candida species isolated and their susceptibility to antifungal drugs in HIV-infected patients, compared to HIV-uninfected women in Salvador, Brazil. Methods: Cross-sectional study including a group of 64 HIV-infected women and 76 uninfected women, followed up at the AIDS reference center and at the Gynecological Clinic of Escola Bahiana de Medicina e Saúde Pública (Salvador, Bahia, Brazil). Results: Frequency of Candida spp. was higher in HIV-infected women (29.7%) than in HIV-uninfected controls (14.5%) (p = 0.02). he odds ratio value for vulvovaginal candidiasis in HIV-infected patients was 2.6 (95% CI: 1.07 -6.32 p = 0.03). Candida albicans was the most commonly isolated species in both HIV-infected (52.3%) and uninfected women (85.7%), followed by C. parapsolis in 17.6% and 14.3%, respectively. In HIV-infected women, C. glabrata, C. parapsilosis, and a coinfection of C. albicans and C. glabrata were also identiied. here was no signiicant diference between Candida species isolated from the vaginal mucosa of women with VVC and colonization of the vaginal mucosa of HIV-infected and HIV-uninfected women. One C. glabrata isolate from an HIV-infected patient was resistant to luconazole and other two isolates exhibited a dose-dependent susceptibility. Conclusion: Our results conirm a higher frequency of Candida spp. isolated from the vaginal mucosa of HIV-infected women and a broader spectrum of species involved. Only Candida glabrata isolates showed decreased susceptibility to luconazole.
INTRODUCTION
Vulvovaginal candidiasis (VVC) is one of the most frequent vaginal infections in the world. 1, 2 It is estimated that 75% of women will have VVC at least once in their lifetime. 3, 4 Clinical signs and symptoms of this infection include itching, white discharge, edema, and erythema of the vulva. [4] [5] [6] Candida albicans, a saprophyte present in the vaginal mucosa, is isolated in 80% of VVC cases. 7, 8 Factors which predispose to VVC include: pregnancy, uncontrolled diabetes mellitus, corticosteroids or systemic/ vaginal antibiotic therapy, HIV infection, and Candida vaginal colonization (CVC). 9, 10 he frequency of VVC caused by other Candida species, such as Candida tropicalis, Candida glabrata, and Candida krusei is increasing, especially in HIV-infected women. 5, 8, 11 C. albicans and C. glabrata are responsible for the majority of VVC cases in HIV-infected women. 10, 12 Although resistance to azoles antifungal therapy is rare in C. albicans isolates (1%), it is becoming commonplace among C. glabrata isolates (up to 15%) as well as among other non-albicans species. 5, 10, 13, 14 Few studies in Brazil have assessed the prevalence of VVC in HIV-infected women undergoing highly active antiretroviral therapy (HAART) treatment. 15 he aim of this study was to determine the frequency of VVC and to describe the main Candida species isolated in HIV-infected patients, compared to HIV-uninfected women in Salvador, Brazil. In addition, the susceptibility of Candida species to antifungal drugs was evaluated.
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MATERIAL AND METHODS

Study population and procedure
A group of sixty-four HIV-infected women receiving care at the AIDS reference center of Bahia (Centro Especializado em Diagnóstico, Assistência e Pesquisa, CEDAP) and 76 HIV-uninfected women from the Gynecology Clinic of Escola Bahiana de Medicina e Saúde Pública (Salvador, Bahia, Brazil) were included in this study, between May 2006 and May 2007.
Patients were sequentially enrolled at the moment of the medical appointment. Inclusion criteria were women aged more than 18 years old, sexually active, positive serology for HIV (HIV group) or negative (control group). Exclusion criteria were: pregnancy or post-partum, intra-vaginal treatment thirty days prior to vaginal collection, vaginal bleeding, sexual intercourse or vaginal douching within the 48 hours preceding vaginal sample collection.
The study was approved by the Institutional Research Boarding of the Fundação Oswaldo Cruz Bahia (Fiocruz -Bahia). All patients signed an informed consent form prior to admission. Candida vaginal≥ colonization≥ was≥ deined≥ as≥ culture≥ isolation≥ of≥ yeasts≥ from≥ asymptomatic≥ women.≥ Women≥ with≥a≥positive≥culture≥were≥considered≥to≥have≥VVC≥if≥they≥ reported≥symptoms≥(vaginal≥itching,≥burning,≥and/or≥disć charge)≥at≥the≥time≥of≥the≥medical≥appointment.
Specimen collection
Statistical analysis
Frequencies≥ of≥ Candida spp.≥ of≥ HIVćinfected≥ women≥ were≥ compared≥ to≥ those≥ of≥ the≥ control≥ group≥ by≥ using≥ t≥ tests≥ for≥ continuous≥ variables≥ and≥ Chićsquare≥ tests≥ or≥ Fisher's≥ exact≥ test≥ for≥ categorical≥ variables.≥ A≥ mulć tiple≥logistic≥regression≥model≥was≥used≥to≥evaluate≥the≥ prediction≥ capacity≥ of≥ each≥ independent≥ variable≥ in≥ the≥ occurrence≥ of≥ the≥ expected≥ condition.≥ Unadjusted≥ odds ratios≥(ORs)≥were≥initially≥calculated≥to≥screen≥for≥ inclusion≥ in≥ the≥ multivariate≥ model;≥ variables≥ that≥ exć hibited≥at≥least≥moderate≥association≥(p≥=≥0.10)≥with≥the≥ outcome≥in≥the≥presence≥of≥these≥design≥variables≥were≥ considered≥for≥inclusion≥in≥the≥final≥models.≥Statistical≥ analysis≥was≥done≥with≥the≥SPSS≥(Statistical≥Package≥for≥ the≥Social≥Sciences)≥13.0. In≥ both≥ HIVćinfected≥ and≥ uninfected≥ women,≥ there≥ was≥no≥significant≥difference≥observed≥in≥the≥frequency≥of≥ a≥particular≥species≥of≥Candida isolated≥from≥the≥vaginal≥ mucosa≥and≥the≥presence≥of≥VVC,≥nor≥was≥there≥a≥differć ence≥in≥the≥frequency≥of≥a≥particular≥species≥of≥Candida colonizing≥the≥vaginal≥mucosa≥(Table≥4).
RESULTS
Only≥ one≥ out≥ of≥ 24≥ yeast≥ isolates,≥ an≥ isolate≥ of≥ ≥ C. glabrata≥from≥an≥HIVćinfected≥patient,≥was≥resistant≥to≥ fluconazole≥(MIC≥>≥256≥mg/L).≥Two≥C. glabrata≥ isolates≥ exhibited≥a≥dosećdependent≥susceptibility≥to≥fluconazole≥ (MIC≥=≥24≥and≥48≥mg/L)≥(Table≥5). 24, 26 In≥ summary,≥ our≥ study≥ found≥ higher≥ prevalence≥ of≥ Candida spp.≥in≥vaginal≥mucosa≥of≥HIVćinfected≥patients≥ than≥uninfected≥women.≥Thus,≥these≥patients≥could≥benć efit≥from≥a≥periodic≥gynecological≥examination≥and≥VVC≥ screening,≥ even≥ when≥ undergoing≥ HAART≥ treatment.≥ ≥ Although≥the≥species≥of≥C. albicans≥is≥the≥most≥frequent,≥ it≥is≥evident≥the≥emergence≥of≥nonćalbicans≥Candida speć cies,≥ including≥ C. glabrata≥ with≥ intrinsic≥ resistance≥ to≥ azoles.≥Therefore,≥alternative≥agents≥to≥treat≥VCC≥caused≥ by≥C. glabrata≥should≥be≥considered.≥
